Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Eric Francois, Denis Smith, Laetitia Dahan, Cecile Michel, Hervé Perrier, Véronique Mari, Jean-François Seitz, Philippe Follana, Ludovic Evesque & Emmanuel Chamorey. (2012) Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study. Journal of Chemotherapy 24:4, pages 207-211.
Read now
Read now
Anastasios Dimou, Kostas N Syrigos & Muhammad Wasif Saif. (2010) Is there a role for mitomycin C in metastatic colorectal cancer?. Expert Opinion on Investigational Drugs 19:6, pages 723-735.
Read now
Read now
Articles from other publishers (3)
Chiara Baratelli, Marco Tampellini, Massimo Di Maio, Azzurra Ottone, Maria Pia Brizzi, Laura Forti, Irene Alabiso, Cristina Sonetto, Oscar Alabiso & Giorgio Vittorio Scagliotti. (2017) MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression. International Journal of Clinical Oncology 23:2, pages 281-286.
Crossref
Crossref
Renata Ferrarotto, Karime Machado, Milena P. Mak, Neeraj Shah, Tiago K. Takahashi, Frederico P. Costa, Michael J. Overman, Scott Kopetz & Paulo M. Hoff. (2012) A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer. European Journal of Cancer 48:6, pages 820-826.
Crossref
Crossref
Laurenz Vormittag, Gabriela V. Kornek, Barbara Gruhsmann, Alfred Lenauer, Andreas Föger, Dieter Depisch, Fritz Lang & Werner Scheithauer. (2007) UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer – a retrospective analysis. Anti-Cancer Drugs 18:6, pages 709-712.
Crossref
Crossref